Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as a new oral delivery of two GLP-1 drugs previously approved by the FDA in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results